Leukapheresis Market Report
First published: 07 October 2024 | Last updated: 25 May 2026 | Report Code: leukapheresis
Leukapheresis Market — USD $1.5 Billion in 2023, Growing to USD 2.95null by 2033 at 6.8% CAGR
This report extensively covers the leukapheresis market, providing insights on market trends, growth forecasts, and segment analysis from 2023 to 2033. The analysis includes regional overviews and leads in the industry, giving a comprehensive picture of current and future market dynamics.
Key Takeaways
- Global market expands from $1.50 Billion in 2023 to $2.95 Billion by 2033 at a 6.8% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe moves from $0.49 Billion in 2023 to $0.97 Billion in 2033, reflecting sustained demand.
- Asia Pacific grows from $0.27 Billion in 2023 to $0.53 Billion in 2033 driven by healthcare investment.
- Key product categories include Leukapheresis Devices and Kits; major companies include Terumo BCT Inc., Fresenius Kabi AG, Haemonetics Corporation and Cerus Corporation.
Leukapheresis Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report outlines the leukapheresis sector’s trajectory from 2023 to 2033, when the market value is expected to increase from $1.50 Billion to $2.95 Billion at a 6.8% CAGR. Growth is supported by rising clinical need for therapeutic apheresis, technological improvements in devices and kits, and expanding applications in hospitals, blood banks and research institutes. Regional breakdowns highlight North America as the largest market, with Europe and Asia Pacific also showing significant expansion. Product, technology and end-user segmentation inform adoption patterns. The competitive landscape features Terumo BCT Inc., Fresenius Kabi AG, Haemonetics Corporation and Cerus Corporation. The analysis combines primary expert interviews and secondary sources to validate trends and market dynamics.
Key Growth Drivers
- Increasing prevalence of hematological disorders and cancer cases creating demand for therapeutic leukapheresis.
- Advances in automated leukapheresis devices and membrane separation methods enhancing procedural efficiency.
- Broader adoption across hospitals, blood banks and research institutes expanding end-user demand.
- Rising healthcare infrastructure investments, particularly in developed health systems, supporting equipment procurement.
- Product diversification with devices and kits enabling wider clinical application and procedural standardization.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $2.95 Billion |
| Top Companies | Terumo BCT Inc., Fresenius Kabi AG, Haemonetics Corporation, Cerus Corporation |
| Published Date | 07 October 2024 |
| Last Modified Date | 25 May 2026 |
Leukapheresis Market Overview
Customize Leukapheresis Market Report market research report
- ✔ Get in-depth analysis of Leukapheresis market size, growth, and forecasts.
- ✔ Understand Leukapheresis's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Leukapheresis
What is the Market Size & CAGR of Leukapheresis Market Report market in 2023?
Leukapheresis Industry Analysis
Leukapheresis Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Leukapheresis Market Report Market Analysis Report by Region
Europe Leukapheresis Market Report:
Europe grows from $0.49 Billion in 2023 to $0.97 Billion in 2033. Adoption in hospitals and blood banks, along with clinical use for cancer treatment and transplantation, underpins market expansion across the region.Asia Pacific Leukapheresis Market Report:
Asia Pacific grows from $0.27 Billion in 2023 to $0.53 Billion in 2033. Healthcare investment, expanding clinical services, and growing use in research institutes and treatment centers support regional growth.North America Leukapheresis Market Report:
North America is largest regional market, rising from $0.52 Billion in 2023 to $1.02 Billion in 2033. Regional demand is driven by established healthcare infrastructure, broad hospital adoption, and availability of advanced leukapheresis devices and kits.South America Leukapheresis Market Report:
Latin America grows from $0.08 Billion in 2023 to $0.15 Billion in 2033. Market progression is linked to increasing clinical awareness, gradual infrastructure improvements, and uptake of devices in specialized treatment centers.Middle East & Africa Leukapheresis Market Report:
Middle East and Africa grows from $0.14 Billion in 2023 to $0.28 Billion in 2033. Growth drivers include expanding hospital services, development of specialized clinics and growing adoption of leukapheresis technology.Tell us your focus area and get a customized research report.
Research Methodology
Leukapheresis Market Analysis By Product
The leukapheresis market is predominantly driven by the demand for leukapheresis devices, which represented 85.95% of the market share in 2023, expected to maintain this lead through to 2033. Secondary to this are leukapheresis kits which account for a growing share of around 14.05%. The technological advancements in these product categories are enhancing their effectiveness and applicability in clinical settings.
Leukapheresis Market Analysis By Application
Cancer treatment remains the primary application area for leukapheresis, commanding about 62.57% of the market. Hematopoietic cell transplantation and autoimmune disorders also constitute significant segments, accounting for 20.52% and 16.91% respectively. The increasing understanding of leukapheresis in autoimmune disease management is contributing to growth in this area.
Leukapheresis Market Analysis By End User
Hospitals dominate the end-user segment, representing around 62.57% of the market in 2023. However, blood banks and research institutes are vital contributors as well, holding 20.52% and 16.91% market shares respectively. Investments in hospital infrastructure and increased treatment capacity are supporting the major end-user segment.
Leukapheresis Market Analysis By Technology
Centrifugation technology leads the market with a significant share of 85.95%, predominantly due to its historical effectiveness and ease of use. Meanwhile, membrane separation technology is also growing, currently holding a share of 14.05%, reflecting advancements in separation techniques and efficiencies.
Leukapheresis Market Analysis By Region
Overall, North America leads in size and share, followed by Europe, which continues to flourish due to supportive regulatory frameworks. The Asia-Pacific region showcases remarkable growth potential, driven by its increasing healthcare investments and patient population.
Leukapheresis Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Leukapheresis Industry
Terumo BCT Inc.:
A leading provider of blood component technology, Terumo BCT is known for its blood collection and processing systems, enhancing leukapheresis effectiveness.Fresenius Kabi AG:
Fresenius Kabi supplies products for hospital and outpatient treatment, including devices crucial for leukapheresis. Their comprehensive approach to blood management supports market growth.Haemonetics Corporation:
Specializing in blood management solutions, Haemonetics develops innovative technologies for apheresis procedures tailored to improve patient outcomes.Cerus Corporation:
Cerus is focused on developing medical devices and blood safety solutions that enhance leukapheresis processes, leveraging advanced technologies for better results.We're grateful to work with incredible clients.
FAQs
What is the market size in 2023?
The market size for leukapheresis in 2023 is $1.50 Billion as reported for the global market.
How big will the market be in 2033?
By 2033 the leukapheresis market is projected to reach $2.95 Billion based on the forecast provided for the period 2023 to 2033.
What is CAGR of the market?
The compound annual growth rate for the forecast period 2023 to 2033 is 6.8% as specified in the report data.
Is there a single fastest Growing region in the Leukapheresis Market Report market?
No single fastest-growing region is stated for the Leukapheresis Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Who are the top companies?
Leading companies listed include Terumo BCT Inc., Fresenius Kabi AG, Haemonetics Corporation and Cerus Corporation in the leukapheresis market.
Why is demand rising?
Demand increases due to higher incidence of blood disorders, expanded therapeutic applications and improvements in device efficiency and procedural outcomes.
What are primary product segments?
Primary product segments are Leukapheresis Devices and Leukapheresis Kits, which support clinical and research apheresis procedures.
How was the research conducted?
Research combined primary interviews with industry experts, secondary company reports and publications, plus data triangulation and internal validation.